Dr. Josiah Allen explains how genetic mutations (like RET) influence the safety of GLP-1 agonists like Ozempic and Wegovy.
All tagged pharmacogenomics
Dr. Josiah Allen explains how genetic mutations (like RET) influence the safety of GLP-1 agonists like Ozempic and Wegovy.
Drs. Eric Green and Brendan Lee join our host Kira Dineen for our annual reflection and recap on the biggest genetics/genomics advancements this year!
Dr. Avni Santani, CMO of Veritas (LetsGetChecked), provides an overview of pharmacogenomics.